Publicaciones en las que colabora con Juan Miguel Ruiz Nodar (40)

2023

  1. High medium-term incidence of major cardiovascular events in discharged patients with unstable angina

    IJC Heart and Vasculature, Vol. 46

2022

  1. Clinical implications of diabetes mellitus in patients with acute coronary syndrome: Prognostic role and use of new P2Y12 receptor inhibitors

    Diabetes Research and Clinical Practice, Vol. 184

  2. Current trends on antithrombotic therapy

    REC: CardioClinics

2021

  1. Comorbidity burden and revascularization benefit in elderly patients with acute coronary syndrome

    Revista Espanola de Cardiologia, Vol. 74, Núm. 9, pp. 765-772

  2. Impact of comorbidities in the decision of using invasive management in elderly patients with NSTEACS

    REC: Interventional Cardiology, Vol. 3, Núm. 1, pp. 15-20

  3. Influencia de las comorbilidades en la decisión del tratamiento invasivo en ancianos con SCASEST

    REC: Interventional Cardiology, Vol. 3, Núm. 1, pp. 15-20

  4. Prognosis impact of diabetes in elderly women and men with non-st elevation acute coronary syndrome

    Journal of Clinical Medicine, Vol. 10, Núm. 19

  5. Sex differences in the management of patients with acute coronary syndrome: A population-based ecological cross-sectional study in Spain

    REC: CardioClinics, Vol. 56, Núm. 3, pp. 168-178

2020

  1. Beneficio del tratamiento invasivo en ancianos con comorbilidades y síndrome coronario agudo sin elevación del ST

    REC: Interventional Cardiology, Vol. 2, Núm. 4, pp. 315-315

  2. One-year efficacy and safety of prasugrel and ticagrelor in patients with acute coronary syndromes: Results from a prospective and multicentre ACHILLES registry

    British Journal of Clinical Pharmacology, Vol. 86, Núm. 6, pp. 1052-1061

  3. Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology

    Revista Espanola de Cardiologia, Vol. 73, Núm. 9, pp. 749-757

  4. Relevancia de la carga de comorbilidades en el manejo invasivo del síndrome coronario agudo en pacientes ancianos

    REC: Interventional Cardiology, Vol. 2, Núm. 4, pp. 316-316

2019

  1. Chronic Kidney Disease and Third-Generation P2Y 12 Inhibitors Use in Patients With Acute Coronary Syndrome: Impact on the Prognosis at 1 Year

    Journal of Clinical Pharmacology, Vol. 59, Núm. 2, pp. 295-302

  2. Switching of Oral P2Y 12 Inhibitor Treatment in Patients with Acute Coronary Syndrome: Prevalence, Predictors, and Prognosis

    Clinical Drug Investigation, Vol. 39, Núm. 3, pp. 275-283

  3. Impact of anemia as risk factor for major bleeding and mortality in patients with acute coronary syndrome

    European Journal of Internal Medicine, Vol. 61, pp. 48-53

  4. Under-prescription of novel antiplatelet drugs in patients with acute coronary syndrome and previous cardiovascular disease

    Minerva Medica, Vol. 110, Núm. 5, pp. 410-418

2018

  1. Conservatively managed patients with non-ST-segment elevation acute coronary syndrome are undertreated with indicated medicines

    PLoS ONE, Vol. 13, Núm. 11

  2. Disparities in the estimation of glomerular filtration rate according to cockcroft-gault, modification of diet in renal disease-4, and chronic kidney disease epidemiology collaboration equations and relation with outcomes in patients with acute coronary syndrome

    Journal of the American Heart Association, Vol. 7, Núm. 9

  3. Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU

    Revista Espanola de Cardiologia, Vol. 71, Núm. 7, pp. 553-564

  4. Temporal Trends in the Use of Antiplatelet Therapy in Patients With Acute Coronary Syndromes

    Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 23, Núm. 1, pp. 57-65